Your browser doesn't support javascript.
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Shaw, Robert H; Stuart, Arabella; Greenland, Melanie; Liu, Xinxue; Nguyen Van-Tam, Jonathan S; Snape, Matthew D.
  • Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Stuart A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Nguyen Van-Tam JS; Division of Epidemiology and Public Health, School of Clinical Sciences, University of Nottingham, Nottingham, UK.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: matthew.snape@paediatrics.ox.ac.uk.
Lancet ; 397(10289): 2043-2046, 2021 05 29.
Article in English | MEDLINE | ID: covidwho-1225435
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / Immunization, Secondary / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01115-6

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / Immunization, Secondary / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01115-6